|
| Recommendations for
Resting ABI for Diagnosing PAD |
|
| COR |
LOE |
Recommendations |
|
| I |
B-NR |
In patients with history or
physical examination findings suggestive of PAD (Table 5), the resting
ABI, with or without segmental pressures and waveforms, is
recommended to establish the diagnosis.64–69
|
|
| See Online Data Supplement
4. |
The resting ABI is obtained by
measuring systolic blood pressures at the arms (brachial arteries)
and ankles (dorsalis pedis and posterior tibial arteries) in the
supine position by using a Doppler device. The ABI of each leg is
calculated by dividing the higher of the dorsalis pedis or posterior
tibial pressure by the higher of the right or left arm blood
pressure.27 In patients with a history or physical
examination suggestive of PAD, the ABI has good validity as a
first-line test in the diagnosis of PAD, as shown by vascular
imaging, with sensitivities ranging from 68% to 84%
and specificities from 84% to 99%.64–69 Segmental lower extremity
blood pressures and Doppler or plethysmographic waveforms (pulse
volume recordings) can be used to localize anatomic segments of
disease (eg, aortoiliac, femoropopliteal, infrapopliteal).34,70,71
|
|
| I |
C-LD |
Resting ABI results should be
reported as abnormal (ABI ≤0.90), borderline (ABI
0.91–0.99), normal (1.00–1.40), or
noncompressible (ABI >1.40).27,67–69,72
|
|
| See Online Data Supplement
4. |
Standardized reporting improves
communication among healthcare providers. Calculated ABI values
should be recorded to 2 decimal places. Patients with ABI
≤0.90 are diagnosed with PAD.67–69 Those with ABI 0.91 to 0.99
may possibly have PAD and should undergo exercise ABI, if the
clinical suspicion of PAD is significant (Tables 4 and 5).73,74
Values >1.40 indicate that the arteries were not able to be
compressed, which is more common among individuals with diabetes
mellitus and/or advanced chronic kidney disease. In the setting of
noncompressible ABI values, additional imaging can be used to
diagnose PAD if the clinical suspicion is significant (Figures 1 and 2).72 These cutpoints for ABI interpretation have
been previously proposed and represent a reasonable standardized
categorization.27
|
|
| IIa |
B-NR |
In patients at increased risk of
PAD (Table
4) but without history or physical examination
findings suggestive of PAD (Table 5), measurement of the
resting ABI is reasonable.54,55,75–97
|
|
| See Online Data
Supplements 3 and 4. |
The ABI test is noninvasive, is simple
to perform, and has minimal risks, making it suitable for use in
asymptomatic individuals. Previous studies have demonstrated a
significant prevalence of abnormal resting ABI among asymptomatic
patients with risk factors for PAD.55,79,95 A
significant body of evidence demonstrates that patients with an
abnormal ABI who are asymptomatic have poorer cardiovascular
morbidity and mortality outcomes than do patients with normal
ABI.79–87 While there is no conclusive evidence that
aspirin treatment changes cardiovascular or limb outcomes in this
population, in 1 cohort study of 5480 patients with asymptomatic
PAD, statin treatment improved cardiovascular outcomes.75–78,96
|
|
| There is also evidence that
asymptomatic patients with a low resting ABI have a poorer
functional status and a more rapid rate of functional decline than
do patients with a normal ABI.54,88–92 Although physical activity has been shown to be
associated with improvement in functional status in patients with
asymptomatic PAD,93,94
the benefit of resting ABI testing to identify asymptomatic patients
who are at increased risk of functional decline and may benefit from
structured exercise programs remains to be determined. |
|
| III: No Benefit |
B-NR |
In patients not at increased risk
of PAD (Table
4) and without history or physical examination
findings suggestive of PAD (Table 5), the ABI is not
recommended.95,98
|
|
| See Online Data Supplement
4. |
The prevalence of PAD among individuals
without risk factors for atherosclerosis and who are <50
years of age is low. Data from population-based cohort studies have
demonstrated a low prevalence (approximately 1%) of abnormal
resting ABI among individuals <50 years of age.95,98 In the NHANES (National
Health and Nutrition Study), approximately 95% of
participants with an abnormal resting ABI had at least 1 risk factor
for atherosclerosis.95 The yield of ABI testing among younger,
asymptomatic individuals without risk factors for atherosclerosis is
low, and these patients should not be routinely tested for
PAD.95,98
|
|